Point of Care Hemoglobin Analyzer Market To Reach USD 1,674.16 Million By 2026 | Reports And Data
/
Date07 Nov 2019
Email Print Friendly Share New York, Nov. 06, 2019 (GLOBE NEWSWIRE) — Growth in demand for anemia screening, demand from blood banks for disease screening,... Read More →
Silvercorp Intersects 1,102 g/t Silver, 16.39% Lead, and 1.55% Zinc Over 1.20 Metres at the SGX Mine, Ying Mining District
/
Date07 Nov 2019
Email Print Friendly Share VANCOUVER, British Columbia, Nov. 06, 2019 (GLOBE NEWSWIRE) — Silvercorp Metals Inc. (“Silvercorp” or the “Company”) (TSX/NYSE American: SVM) is pleased... Read More →
ISC® Declares Quarterly Dividend
/
Date07 Nov 2019
Email Print Friendly Share REGINA, Saskatchewan, Nov. 06, 2019 (GLOBE NEWSWIRE) — The Board of Directors of Information Services Corporation (TSX:ISV) (“ISC” or the “Company”)... Read More →
Alio Gold Reports Third Quarter 2019 Results
/
Date07 Nov 2019
Email Print Friendly Share VANCOUVER, British Columbia, Nov. 06, 2019 (GLOBE NEWSWIRE) — Alio Gold Inc. (TSX, NYSE AMERICAN: ALO) (“Alio Gold” or the “Company”)... Read More →
OraSure Technologies, Inc. Announces Purchase of Diversigen
/
Date07 Nov 2019
Email Print Friendly Share BETHLEHEM, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and... Read More →
David Gokhshtein of G Media: Announces Congressional Run
/
Date07 Nov 2019
Email Print Friendly Share NEW YORK, NY, Nov. 06, 2019 (GLOBE NEWSWIRE) — (via Blockchain Wire) Gokhshtein Media is a multi-platform media and marketing company comprised... Read More →
Italeaf: The Shareholders' Meeting of TerniEnergia approves the results as at 31 December 2018. Appointment of the new Board of Directors
/
Date07 Nov 2019
Email Print Friendly Share PRESS RELEASE 6 NOVEMBER 2019 Italeaf: The Shareholders’ Meeting of TerniEnergia approves the results as at 31 December 2018. Appointment of... Read More →
Correction: ObsEva SA to Hold Conference Call to Discuss IMPLANT 4 Trial Results and Third Quarter 2019 Financial and Business Update on November 7, 2019
/
Date07 Nov 2019
Email Print Friendly Share Geneva, Switzerland and Boston, MA –November 6, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a biopharmaceutical company developing... Read More →
Galera Therapeutics Announces Pricing of Initial Public Offering
/
Date07 Nov 2019
Email Print Friendly Share MALVERN, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and... Read More →